Login to Your Account



Forum: Low value the groundhog shadow for U.S. health care spending

By Mari Serebrov
Regulatory Editor

Friday, February 2, 2018

Drug prices often are the go-to target when it comes to grappling with the growth of health spending in the U.S. But rather than blaming one sector or another, policy-makers need to go below the surface to explore the tough issues that can lead to change, Robert Dubois, chief science officer and executive vice president of the National Pharmaceutical Council (NPC), said Thursday at a forum on health spending.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription